NUVALENT INC-A (NUVL) Stock Analyst Ratings
USA - NASDAQ:NUVL - US6707031075 - Common Stock
99.32 USD
+1.15 (+1.17%)
99.32 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 86% to NUVL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 121.85. This target is 22.68% above the current price.
NUVL was analyzed by 20 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about NUVL.
In the previous month the buy percentage consensus was at a similar level.
NUVL was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-10-31 | UBS | Maintains | Buy -> Buy |
| 2025-10-31 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-27 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-10-16 | Stifel | Reiterate | Buy |
| 2025-10-15 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-09-08 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-09-03 | Raymond James | Initiate | Outperform |
| 2025-08-19 | Piper Sandler | Initiate | Overweight |
| 2025-06-25 | Baird | Maintains | Outperform -> Outperform |
| 2025-06-24 | Leerink Partners | Maintains | Outperform -> Outperform |
| 2025-06-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-14 | UBS | Upgrade | Neutral -> Buy |
| 2025-03-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-30 | HC Wainwright & Co. | Initiate | Buy |
| 2024-11-13 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-10-24 | UBS | Initiate | Neutral |
| 2024-10-04 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-09-16 | Guggenheim | Maintains | Buy -> Buy |
| 2024-09-16 | BMO Capital | Maintains | Outperform -> Outperform |
| 2024-09-16 | Stifel | Maintains | Buy -> Buy |
| 2024-09-16 | Wedbush | Maintains | Outperform -> Outperform |
| 2024-09-09 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-09-04 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-08-29 | Barclays | Initiate | Overweight |
| 2024-07-10 | Stifel | Maintains | Buy -> Buy |
| 2024-05-17 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-04-17 | Jefferies | Initiate | Buy |
| 2024-04-01 | Leerink Partners | Upgrade | Market Perform -> Outperform |
| 2024-03-06 | JP Morgan | Maintains | Overweight -> Overweight |
NUVALENT INC-A / NUVL FAQ
What is the average price target for NUVALENT INC-A (NUVL) stock?
20 analysts have analysed NUVL and the average price target is 121.85 USD. This implies a price increase of 22.69% is expected in the next year compared to the current price of 99.32.
What is the consensus rating for NUVL stock?
The consensus rating for NUVALENT INC-A (NUVL) is 86 / 100 . This indicates that analysts generally have a positive outlook on the stock.